- Home
- PK vs RXRX Comparison
PK vs RXRX Comparison
Compare PK & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PK
- RXRX
- Stock Information
- Founded
- PK 1946
- RXRX 2013
- Country
- PK United States
- RXRX United States
- Employees
- PK N/A
- RXRX N/A
- Industry
- PK Real Estate Investment Trusts
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- PK Real Estate
- RXRX Health Care
- Exchange
- PK Nasdaq
- RXRX Nasdaq
- Market Cap
- PK 2.1B
- RXRX 2.0B
- IPO Year
- PK N/A
- RXRX 2021
- Fundamental
- Price
- PK $10.71
- RXRX $5.20
- Analyst Decision
- PK Hold
- RXRX Buy
- Analyst Count
- PK 11
- RXRX 5
- Target Price
- PK $12.85
- RXRX $7.00
- AVG Volume (30 Days)
- PK 4.1M
- RXRX 33.0M
- Earning Date
- PK 07-31-2025
- RXRX 08-07-2025
- Dividend Yield
- PK 13.11%
- RXRX N/A
- EPS Growth
- PK 45.67
- RXRX N/A
- EPS
- PK 0.61
- RXRX N/A
- Revenue
- PK $2,602,000,000.00
- RXRX $59,790,000.00
- Revenue This Year
- PK $2.49
- RXRX $23.51
- Revenue Next Year
- PK $3.25
- RXRX $53.87
- P/E Ratio
- PK $17.53
- RXRX N/A
- Revenue Growth
- PK N/A
- RXRX 29.32
- 52 Week Low
- PK $8.27
- RXRX $3.79
- 52 Week High
- PK $16.23
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- PK 57.04
- RXRX 53.82
- Support Level
- PK $10.12
- RXRX $4.91
- Resistance Level
- PK $10.88
- RXRX $5.44
- Average True Range (ATR)
- PK 0.30
- RXRX 0.36
- MACD
- PK 0.05
- RXRX 0.01
- Stochastic Oscillator
- PK 83.33
- RXRX 62.50
About PK Park Hotels & Resorts Inc.
Park Hotels & Resorts owns upper-upscale and luxury hotels with 22,711 rooms across 37 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of narrow-moat Hilton Worldwide Holdings at the start of 2017, so most of the company's hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.